Shenzhen New Industries Biomedical (300832) - Total Liabilities

Latest as of September 2025: CN¥831.98 Million CNY ≈ $121.74 Million USD

Based on the latest financial reports, Shenzhen New Industries Biomedical (300832) has total liabilities worth CN¥831.98 Million CNY (≈ $121.74 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shenzhen New Industries Biomedical (300832) cash flow conversion to assess how effectively this company generates cash.

Shenzhen New Industries Biomedical - Total Liabilities Trend (2012–2024)

This chart illustrates how Shenzhen New Industries Biomedical's total liabilities have evolved over time, based on quarterly financial data. Check 300832 financial resilience to evaluate the company's liquid asset resilience ratio.

Shenzhen New Industries Biomedical Competitors by Total Liabilities

The table below lists competitors of Shenzhen New Industries Biomedical ranked by their total liabilities.

Company Country Total Liabilities
Clal Insurance Enterprises Holdings Ltd
TA:CLIS
Israel ILA173.51 Billion
Reinet Investments SCA
JSE:RNI
South Africa ZAC2.00 Million
Olympic Circuit Technology Co Ltd
SHG:603920
China CN¥3.01 Billion
PTT Global Chemical Public Company Limited
BK:PTTGC
Thailand ฿310.60 Billion
Compagnie de l'Odet
PA:ODET
France €1.76 Billion
Porsche Automobil Holding SE
XETRA:PAH3
Germany €7.12 Billion
Jiangsu Lettall Electronic Co Ltd
SHG:603629
China CN¥4.09 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Shenzhen New Industries Biomedical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300832 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 7.65 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen New Industries Biomedical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen New Industries Biomedical (2012–2024)

The table below shows the annual total liabilities of Shenzhen New Industries Biomedical from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥1.04 Billion
≈ $152.60 Million
+53.79%
2023-12-31 CN¥678.09 Million
≈ $99.23 Million
+10.25%
2022-12-31 CN¥615.06 Million
≈ $90.00 Million
+17.49%
2021-12-31 CN¥523.51 Million
≈ $76.61 Million
+4.39%
2020-12-31 CN¥501.49 Million
≈ $73.38 Million
+57.24%
2019-12-31 CN¥318.92 Million
≈ $46.67 Million
+16.17%
2018-12-31 CN¥274.52 Million
≈ $40.17 Million
+9.81%
2017-12-31 CN¥250.00 Million
≈ $36.58 Million
+34.59%
2016-12-31 CN¥185.75 Million
≈ $27.18 Million
+48.66%
2015-12-31 CN¥124.94 Million
≈ $18.28 Million
-7.39%
2014-12-31 CN¥134.92 Million
≈ $19.74 Million
-16.78%
2013-12-31 CN¥162.12 Million
≈ $23.72 Million
+149.68%
2012-12-31 CN¥64.93 Million
≈ $9.50 Million
--

About Shenzhen New Industries Biomedical

SHE:300832 China Medical Devices
Market Cap
$5.55 Billion
CN¥37.91 Billion CNY
Market Cap Rank
#3348 Global
#502 in China
Share Price
CN¥48.25
Change (1 day)
-0.29%
52-Week Range
CN¥44.82 - CN¥70.18
All Time High
CN¥98.01
About

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was found… Read more